1. Home
  2. INDB vs BLTE Comparison

INDB vs BLTE Comparison

Compare INDB & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDB
  • BLTE
  • Stock Information
  • Founded
  • INDB 1907
  • BLTE 2018
  • Country
  • INDB United States
  • BLTE United States
  • Employees
  • INDB N/A
  • BLTE N/A
  • Industry
  • INDB Major Banks
  • BLTE Biotechnology: Pharmaceutical Preparations
  • Sector
  • INDB Finance
  • BLTE Health Care
  • Exchange
  • INDB Nasdaq
  • BLTE Nasdaq
  • Market Cap
  • INDB 2.4B
  • BLTE 2.1B
  • IPO Year
  • INDB N/A
  • BLTE 2022
  • Fundamental
  • Price
  • INDB $66.02
  • BLTE $64.12
  • Analyst Decision
  • INDB Strong Buy
  • BLTE Strong Buy
  • Analyst Count
  • INDB 3
  • BLTE 4
  • Target Price
  • INDB $73.67
  • BLTE $89.00
  • AVG Volume (30 Days)
  • INDB 283.8K
  • BLTE 62.6K
  • Earning Date
  • INDB 01-16-2025
  • BLTE 11-12-2024
  • Dividend Yield
  • INDB 3.45%
  • BLTE N/A
  • EPS Growth
  • INDB N/A
  • BLTE N/A
  • EPS
  • INDB 4.60
  • BLTE N/A
  • Revenue
  • INDB $655,494,000.00
  • BLTE N/A
  • Revenue This Year
  • INDB N/A
  • BLTE N/A
  • Revenue Next Year
  • INDB $5.18
  • BLTE N/A
  • P/E Ratio
  • INDB $14.35
  • BLTE N/A
  • Revenue Growth
  • INDB N/A
  • BLTE N/A
  • 52 Week Low
  • INDB $45.11
  • BLTE $31.01
  • 52 Week High
  • INDB $77.23
  • BLTE $86.53
  • Technical
  • Relative Strength Index (RSI)
  • INDB 37.13
  • BLTE 44.50
  • Support Level
  • INDB $70.29
  • BLTE $60.00
  • Resistance Level
  • INDB $71.81
  • BLTE $76.87
  • Average True Range (ATR)
  • INDB 2.00
  • BLTE 4.51
  • MACD
  • INDB -0.99
  • BLTE -0.44
  • Stochastic Oscillator
  • INDB 14.69
  • BLTE 24.42

About INDB Independent Bank Corp.

Independent Bank Corp is a bank holding company and the sole shareholder of its bank, the Rockland Trust Company. Rockland is a community-oriented commercial bank. The bank provides a variety of banking, investment and financial services, operating with various retail branches, as well as a network of commercial and residential lending centers, and investment management offices majorly in Eastern Massachusetts, Worcester County, and Rhode Island. The bank's loan portfolio constitutes the bulk of the bank's total assets. Its borrowers consist mostly of small to medium-size businesses and consumers, majority of which are made to its market area in eastern Massachusetts and Rhode Island. The bank's loan portfolio is predominantly in commercial loans.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: